Effects of low dose zinc supplementation on biochemical markers in non-alcoholic cirrhosis: A randomized clinical trial

Archives of Iranian Medicine

Volumn 15, Issue 8, 2012, Pages 472-476

  Somi, Mohammad Hossein ^a   Rezaeifar, Parisa ^a   Rahimi, Alireza Ostad ^a   Moshre, Behnaz ^a  

^a TABRIZ UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Cirrhosis; Clinical trial; Zinc supplementation

Indexed keywords

ALBUMIN; BIOLOGICAL MARKER; COPPER; CREATININE; IRON; NITROGEN; PLACEBO; UREA; ZINC; ZINC SULFATE;

ADULT; AGED; ALBUMIN BLOOD LEVEL; ARTICLE; CONTROLLED STUDY; COPPER BLOOD LEVEL; DIET SUPPLEMENTATION; DISEASE EXACERBATION; DOUBLE BLIND PROCEDURE; FEMALE; HUMAN; IRON BLOOD LEVEL; LIVER CIRRHOSIS; LOW DRUG DOSE; MAJOR CLINICAL STUDY; MALE; RANDOMIZED CONTROLLED TRIAL; ZINC BLOOD LEVEL;

ADULT; AGED; BIOLOGICAL MARKERS; DIETARY SUPPLEMENTS; DOUBLE-BLIND METHOD; FEMALE; HUMANS; LIVER CIRRHOSIS; MALE; MIDDLE AGED; YOUNG ADULT; ZINC;

EID: 84864761375     PISSN: 10292977     EISSN: 17353947     Source Type: Journal    
DOI: None     Document Type: Article

References (38)

1. Gonzalez-Reimers E, Lopez-Lirola A, Olivera RM, Santolaria-Fernandez F, Galindo-Martin L, Breu-Gonzalez P, et al. Effects of protein deficiency on liver trace elements and antioxidant activity in carbon tetrachloride-induced liver cirrhosis. Biol Trace Elem Res. 2003; 93: 127-140.
2. Suddle A, Foster G, Powell-Tuck J. The nutritional and metabolic management of hepatic failure in European liver units-a surprising lack of consensus. Clin Nutr. 2004; 23: 953-954.
3. Henkel AS, Buchman AL. Nutritional support in patients with chronic liver disease. Nat Clin Pract Gastroenterol Hepatol. 2006; 3: 202-209.
4. Campillo B, Richardet JP, Scherman E, Bories PN. Evaluation of nutritional practice in hospitalized cirrhotic patients: results of a prospective study. Nutrition. 2003; 19: 515-521.
5. Rodriguez-Moreno F, Gonzalez-Reimers E, Santolaria-Fernandez F, Galindo-Martin L, Hernandez-Torres O, Batista-Lopez N, et al. Zinc, copper, manganese, and iron in chronic alcoholic liver disease. Alcohol. 1997; 14: 39-44.
6. Loguercio C, De Girolamo V, Federico A, Feng SL, Crafa E, Cataldi V, et al. Relationship of blood trace elements to liver damage, nutritional status, and oxidative stress in chronic nonalcoholic liver disease. Biol Trace Elem Res. 2001; 81: 245-254.
7. Lopez-Lirola A, Gonzalez-Reimers E, Martin OR, Santolaria-Fernandez F, Galindo-Martin L, Breu-Gonzalez P, et al. Protein deficiency and muscle damage in carbon tetrachloride induced liver cirrhosis. Food Chem Toxicol. 2003; 41: 1789-1797.
8. Loguercio C, De Girolamo V, Federico A, Feng SL, Cataldi V, Del Vecchio Blanco C, et al. Trace elements and chronic liver diseases. J Trace Elem Med Biol. 1997; 11: 158-161.
9. Nakayama A, Fukuda H, Ebara M, Hamasaki H, Nakajima K, Sakurai H. A new diagnostic method for chronic hepatitis, liver cirrhosis, and hepatocellular carcinoma based on serum metallothionein, copper, and zinc levels. Biol Pharm Bull. 2002; 25: 426-431.
10. Lin CC, Huang JF, Tsai LY, Huang YL. Selenium, iron, copper, and zinc levels and copper-to-zinc ratios in serum of patients at different stages of viral hepatic diseases. Biol Trace Elem Res. 2006; 109: 15-24.
11. Somi MH, Ostadrahimi A, Moshrefi B, Rezaeifar P, Maghami JG. Nutritional status and blood trace elements in cirrhotic patients. Hep Mon. 2006; 7: 27-32.
12. Federico A, Iodice P, Del Rio A, Mellone A, Catalano MC, Federico P. Effects of selenium and zinc supplementation on nutritional status in patients with cancer of digestive tract. Eur J Clin Nutr. 2001; 55: 293-297.
13. Kratz A, Ferraro M, Sluss PM, Lewandrowski KB. Laboratory Reference Values. N Engl J Med. 2004; 351: 2461.
14. Grungreiff K, Reinhold D. Liver cirrhosis and "liver" diabetes mellitus are linked by zinc deficiency. Med Hypotheses. 2005; 64: 316-317.
15. Kojima-Yuasa A, Ohkita T, Yukami K, Ichikawa H, Takami N, Nakatani T, et al. Involvement of intracellular glutathione in zinc deficiencyinduced activation of hepatic stellate cells. Chem Biol Interact. 2003; 146: 89-99.
16. Yoshida Y, Higashi T, Nouso K, Nakatsukasa H, Nakamura SI, Watanabe A, et al. Effects of zinc deficiency/zinc supplementation on ammonia metabolism in patients with decompensated liver cirrhosis. Acta Med Okayama. 2001; 55: 349-355.
17. Keeling PW, Ruse W, Bull J, Hannigan B, Thompson RP. Direct measurement of the hepatointestinal extraction of zinc in cirrhosis and hepatitis. Clin Sci (Lond). 1981; 61: 441-444.
18. Grungreiff K, Reinhold D, Ansorg S. Serum concentrations of sIL-2R, IL-6, TGF-beta1, neopterin, and zinc in chronic hepatitis C patients treated with interferon-alpha. Cytokine. 1999; 11: 1076-1080.
19. Pramoolsinsap C, Promvanit N, Komindr S, Lerdverasirikul P, Srianujata S. Serum trace metals in chronic viral hepatitis and hepatocellular carcinoma in Thailand. J Gastroenterol.1994; 29: 610-615.
20. Bianchi GP, Marchesisni G, Birizi M, Rossi B, Fornali G, Boni P, et al. Nutritional effects of oral zinc supplementation in cirrhosis. Nutr Res.2000; 20: 1079-1089.
21. Thiele DJ. Integrating trace element metabolism from cell to the whole organism. J Nutr. 2003; 133: 1579S-1580S.
22. Shim H, Leah Harris Z. Genetic defects in copper metabolism. J Nutr. 2003; 133: 1527S-1531S.
23. Theocharis SE, Margeli AP, Koutselinis A. Metallothionein: a multifunctional protein from toxicity to cancer. Int JBiol Markers. 2003; 18: 162-169.
24. Theocharis SE, Margeli AP, Klijanienko JT, Kouraklis GP. Metallothionein expression in human neoplasia. Histopathology. 2004; 45: 103-118.
25. Henkel G, Krebs B. Metallothioneins: zinc, cadmium, mercury, and copper thiolates and selenolates mimicking protein active site features-structural aspects and biological implications. Chem Rev. 2004; 104: 801-824.
26. Mulder TP, Janssens AR, Verspaget HW, van Hattum J, LamersCB. Metallothionein concentration in the liver of patients with Wilson's disease, primary biliary cirrhosis, and liver metastasis of colorectal cancer. J Hepatol. 1992; 16: 346-350.
27. Brewer GJ, Yuzbasiyan-Gurkan V, Lee DY, Appelman H. Treatment of Wilson's disease with zinc. VI. Initial treatment studies. J Lab Clin Med. 1989; 114: 633-638.
28. Hatano R, Ebara M, Fukuda H, Yoshikawa M, Sugiura N, Kondo F, et al. Accumulation of copper in the liver and hepatic injury in chronic hepatitis C. J Gastroenterol Hepatol. 2000; 15: 786-791.
29. Riley TR, Bhatti AM. Preventive strategies in chronic liver disease: part I. Alcohol, vaccines, toxic medications and supplements, diet and exercise. Am Fam Phys. 2001; 64: 1555-1560.
30. Arakawa Y, Moriyama M, Arakawa Y. Liver cirrhosis and metabolism (sugar' protein' fat, and trace elements). Hepatol Res. 2004; 30: 46-58.
31. Jurczyk K, Syczewska M, Kaczmarska A, Sych Z. Serum iron parameters in patients with alcoholic and chronic cirrhosis and hepatitis. Med Sci Monit. 2001; 7: 962-965.
32. Zhao M, Matter K, Laissue JA, Zimmermann A. Copper/zinc and manganese superoxide dismutase immunoreactivity in hepatic iron overload diseases. Histopathol 1995; 10: 925-935.
33. Grüngreiff K, Grüngreiff S, Reinhold D. Zinc deficiency and Hepatic encephalopathy: results of a long-term follow up on zinc supplementation. J Trace Elem Exp Med.2000; 13: 21-31.
34. Marchesini G, Fabbri A, Bianchi G, Brizi M, Zoli M. Zinc supplementation and amino acid-nitrogen metabolism in patients with advanced cirrhosis. Hepatology.1996; 23: 1084-1092.
35. Gimenez A, Pares A, Alie S, Camps J, Deulofeu R, Caballeria J, et al. Fibrogenic and collagenolytic activity in carbon-tetrachloride-injured rats: beneficial effects of zinc administration. J Hepatol. 1994; 21: 292-298.
36. Sato S, Shimizu M, Hosokawa T, Saito T, Okabe M, Niioka T, et al. Distribution of zinc-binding metallothionein in cirrhotic liver of rats administered zinc. Pharmacol Toxicol. 2004; 87: 292-296.
37. Child CG, Turcotte JG. Surgery and portal hypertension. In: Child CG, ed. The Liver and Portal Hypertension. Philadelphia: Saunders; 1964: 50-64.
38. Reding P, Duchateau J, Bataille C. Oral zinc supplementation improves hepatic encephalopathy. Results of a randomized controlled trial. Lancet. 1984; 2: 493-495.